Chemical substances maker Anupam Rasayan has repaid debt price Rs 530 crore from the online proceeds of its just lately accomplished preliminary public providing and can clear a further Rs 30 crore debt by subsequent quarter ending September, 2021.
The corporate had raised Rs 760 crore by means of its Preliminary Public Providing (IPO).
Chatting with PTI, Anupam Rasayan Chief Monetary Officer (CFO) and spokesperson Afzal Malkani mentioned the corporate’s whole debt is about Rs 840 crore.
The target of the IPO was to boost Rs 760 crore, out of which Rs 560 crore was for compensation of the debt and the remaining was for normal company functions, he mentioned.
The corporate has repaid Rs 470 crore debt as on March 31, 2021 and one other Rs 60 crore was repaid within the present quarter, he mentioned and added that to this point a complete of Rs 530 crore debt has been cleared by the corporate.
“The remaining Rs 30 crore will likely be repaid both within the present or by subsequent quarter ending September 2021,” he mentioned.
A complete of Rs 560 crore debt out of Rs 840 crore, will likely be cleared by the subsequent quarter and the remaining debt will likely be on the corporate’s books, he added.
In response to Malkani, the stability Rs 200 crore funds from the IPO proceeds can be used for normal company functions.
About Rs 160 crore has been put aside for value discount measures and the remaining for working capital, he famous.
For example, about Rs 40 crore funds is being utilised for set up of the photo voltaic panel which can assist the corporate scale back its power value by Rs 10 crore yearly, he defined.
On future plans, Malkani mentioned the corporate’s focus until 2023-24 fiscal can be on absolutely utilising the prevailing capability of the crops that had been commercialised this yr.
Anupam Rasayan had invested Rs 400 crore on two crops that had been commercialised this yr. Within the present yr, the corporate plans to utilise 75 per cent of the capability of each the crops and within the following yr make the most of 90 per cent of the capability, he mentioned.
“Until FY’23, our progress will come from the newly commercialised models. Until 2023, we want not fear in regards to the progress,” he mentioned.
Malkani mentioned that the corporate was rising at 34 per cent Compound Annual Development Fee (CAGR) within the final three years and expects the momentum to proceed.
“For that, we do not even want capital expenditure. We might require capex for some minor modification and upkeep, which we will do from the corporate’s inside accruals,” he mentioned.
Stating that there’s scope for progress within the speciality chemical compounds enterprise in India, Malkani mentioned the corporate has already utilized for a few merchandise underneath the federal government’s production-linked incentive (PLI) scheme and can apply for just a few extra merchandise subsequent month.
Nevertheless, this may yield outcomes from the 2023-24 fiscal onwards, he added.
The worldwide speciality chemical compounds market is rising at 11-12 per cent yearly. India accounts for two per cent of the overall market share, which signifies that there’s big scope for brand spanking new enterprise, he added.
Anupam Rasayan had posted a 52.50 per cent soar in its consolidated web revenue at Rs 70.3 crore within the 2020-21 fiscal, from Rs 53.20 crore within the earlier yr, as per a regulatory submitting.
Shares of the corporate had been buying and selling at Rs 763.60 apiece, up 0.80 per cent on the BSE.
(Solely the headline and movie of this report might have been reworked by the Enterprise Normal workers; the remainder of the content material is auto-generated from a syndicated feed.)